Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Investor Conference Call on Thursday, 03rdAugust 2023 at 12 noon (IST) for Q1FY24. Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company will be held on Wednesday, 2nd August 2023, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on 30th June 2023. Further, in continuation of our earlier letter dated 29th June 2023 under subject 'Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prevention of Insider Trading'', the trading window for trading in the securities of the Company shall remain closed upto 48 hours after the declaration of unaudited standalone and consolidated financial results of the Company for the quarter ended on 30th June 2023. Mankind Pharma Ltd - 543904 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a copy of the certificate received from Kfin Technologies Limited, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th June 2023. You are requested to kindly take the same on records.
Surge in grey market premium shows rising interest in public issues
Recently listed Mankind Pharma surged over 30 percent on listing day from its price band while Ikio Lighting Ltd shares debuted over 56 percent premium from its issue price Mankind Pharma Ltd - 543904 - Closure of Trading Window
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct for Prevention of Insider Trading Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Performance and Business Update Call for Q4FY23 & FY23 held on Wednesday, 31st May 2023. The transcript is also available on the website of the Company at https://www.mankindpharma.com/media/investor/q4-fy23-transcript-1686050139.pdf Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 31st May 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230531147437-1685528185.mp3
Mankind Pharma Results Earnings Call for Q4FY23
Conference Call with Mankind Pharma Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript. Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith extracts of the consolidated audited financial results for the quarter and financial year ended 31st March 2023 as published in "Business Standard", 'Financial Express' and "Jansatta" on 31st May 2023. Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
In pursuant to the provisions of Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ('PIT Regulations'), please find enclosed herewith a copy of 'Code of Practice and Procedure for Fair Disclosure of Unpublished Price Sensitive Information' ('Fair Disclosure Code'). The copy of the Fair Disclosure Code is also available on the website of the Company.